Patient characteristics by graft type and dry eye status
| Dry eye after SCT | Allograft recipients | Autograft recipients | ||
|---|---|---|---|---|
| + | − | − | ||
| Number | 22 | 22 | 9 | |
| Dry eye before SCT | 4 | 3 | 2 | |
| Sex (F:M) | 9:13 | 7:15 | 8:1 | |
| Age, mean (SD) | 36.0 (8.0) | 27.0 (10.7) | 42.9 (8.8) | |
| Stem cell source R:U | 12:10 | 17:5 | ||
| Acute GVHD (%) | 17 (77.3%) | 11 (50.0%) | 0 | |
| Underlying diseases | ||||
| AML | 6 | 10 | 2 | |
| ALL | 5 | 5 | 0 | |
| CML | 5 | 4 | 0 | |
| NHL | 0 | 0 | 4 | |
| HD | 0 | 1 | 1 | |
| MDS | 4 | 0 | 0 | |
| MM | 2 | 0 | 1 | |
| Aplastic anaemia | 0 | 2 | 0 | |
| Breast Ca | 0 | 0 | 1 | |
SCT = stem cell transplantation; AML = acute myeloid leukaemia; ALL = acute lymphoblastic leukaemia; CML = chronic myeloid leukaemia; NHL = non-Hodgkin’s lymphoma; HD = Hodgkin’s disease; MDS = myelodysplastic syndrome; MM = multiple myeloma; Ca = carcinoma; R = related donor; U = unrelated donor.